Literature DB >> 53432

Treatment of diabetes insipidus with carbamazepine.

J K Wales.   

Abstract

Oral carbamazepine has been shown to have antidiuretic activity in seven out of nine patients with neurohypophyseal diabetes insipidus. At the doses used side-effects were not a major problem. In the eighth patient a carbamazepine and clofibrate combination was effective but in the ninth carbamazepine was without effect. It is suggested that carbamazepine should be used initially in neurohypophyseal diabetes insipidus if oral therapy is indicated, but the mode of its antidiuretic action is as yet unclear.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53432     DOI: 10.1016/s0140-6736(75)90361-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  Serum sodium and osmolality during carbamazepine treatment in children.

Authors:  I Helin; K O Nilsson; I Bjerre; P Vegfors
Journal:  Br Med J       Date:  1977-08-27

2.  Transient Diabetes Insipidus Following Thermal Burn; A Case Report and Literature Review.

Authors:  Suvashis Dash; Shibajyoti Ghosh
Journal:  Bull Emerg Trauma       Date:  2017-10

3.  Severe hematologic and neurologic reaction to carbamazepine.

Authors:  P J Minich; W A Young
Journal:  Can Med Assoc J       Date:  1985-05-01       Impact factor: 8.262

4.  Water intoxication due to carbamazepine.

Authors:  W P Stephens; M L Espir; R B Tattersall; N P Quinn; S R Gladwell; A W Galbraith; E H Reynolds
Journal:  Br Med J       Date:  1977-03-19

5.  Hyponatraemia during carbamazepine treatment.

Authors:  D A Henry; D H Lawson; P Reavey; S Renfrew
Journal:  Br Med J       Date:  1977-01-08

6.  Rapid development of hyponatraemia during low-dose carbamazepine therapy.

Authors:  L Appleby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

Review 7.  Drug-induced electrolyte abnormalities.

Authors:  E P Brass; W L Thompson
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

8.  Interferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: A case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy.

Authors:  Midori Tanaka; Kyuzi Kamoi; Toru Takahashi
Journal:  Int J Gen Med       Date:  2008-11-30

9.  Transepithelial water movement in response to carbamazepine, chlorpropamide and demeclocycline in toad urinary bladder.

Authors:  M R Hirji; J C Mucklow
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

10.  The clinical challenge of SIADH-three cases.

Authors:  Nils van der Lubbe; Christopher J Thompson; Robert Zietse; Ewout J Hoorn
Journal:  NDT Plus       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.